- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02055443
Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain (MID-EPIC)
The purpose of this study is to evaluate whether new novel markers from the clinical electrocardiogram (EKG), which have been used as non-invasive measures of heart disease, can detect coronary artery disease in patients with chest pain. The researchers are especially interested in studying how changes in these unique waves evolve over time with rest and activity. It is hoped that the findings will be helpful in differentiating patients with cardiac chest pain at emergency departments from those with non-cardiac chest pain, as early identification can accelerate treatment and save lives.
Eligible participants are those age 18 and older who have been referred for a nuclear stress test at University of Pittsburgh Medical Center Presbyterian Hospital to rule out coronary artery disease as part of their clinical care.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute Coronary Syndrome (ACS) is the leading cause of death worldwide. Differentiating ACS from other non-ischemic chest pain is imperative in emergency medicine and missed myocardial infarction remains one of the highest sources of medical malpractice in Emergency Departments (ED). At the same time, economic pressures and limited resources demand that physicians avoid hospital admission or protracted observation for every patient with chest pain or suspicious symptoms. In the absence of clear ST elevation (STE) on the electrocardiogram (ECG), ED providers have no reliable tools to quickly triage non-STE (NSTE) ACS patients. Current guidelines rely on blood biomarkers (e.g. cardiac enzymes) to identify this syndrome and do not completely describe ischemic ECG changes associated with it. ED Providers will need to delay the management of these high risk patients until cardiac biomarkers are withdrawn, analyzed, and interpreted. This results in greater mortality rates in NSTE-ACS patients and overburdens the healthcare system. The prolonged observation times at EDs and unnecessary admissions are just additional consequences that overuse nursing times and exacerbate nursing shortage.
ECG changes other than ST elevation and dynamic ECG changes are a rich opportunity for improving diagnostics. This proposal intends to provide new insights into how ischemic repolarization changes evolve over time in the subacute phase of myocardial ischemia. Sixty patients with suspected coronary artery disease referred for nuclear cardiac stress testing will be included. Resting 12-lead ECGs will be obtained before the stress test and one after the stress test but before the nuclear scan. Alterations in novel, computerized T wave indices will be correlated with focal myocardial ischemia seen on nuclear scans. Repeated Measures ANOVA with between group comparisons, and Generalized Estimation Equation will be used in the analysis. The results will provide insight on the diagnostic value of different novel T wave indices to detect myocardial ischemia. Results from this study will provide tools for ED providers to distinguish ACS from non-ischemic chest pain patients early in the triage process, especially in the absence of STE that constitutes the common standard nowadays.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- adults > 18 years of age
- referred for nuclear cardiac stress testing for suspected coronary artery disease.
There will be no restrictions to sex or race. Children and teens are less likely to have ischemic etiology of chest pain, justifying their exclusion. To optimize the clinical utility, there will be no exclusion criteria based on previous medical history, medications, or presenting chief complaint; all consecutive patients will be eligible.
Exclusion Criteria:
- Patients with un-interpretable ECGs or their ECG shows known secondary repolarization abnormalities (i.e. bundle branch blocks, ventricular hypertrophy, channelopathies, early repolarization) will be excluded. Of note, as per clinical guidelines, these patients do not get usually referred for exercise treadmill testing. This will improve the recruitment process of this study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Holter monitor group
12-lead holter monitor application
|
-- The study coordinator will then obtain a 5-minute baseline high resolution (1000 samples/second), 12-lead resting ECG stream using H12+ holter ECG machine (Mortara Instruments, Milwaukee, WI). This ECG will be performed before the subject completed their clinical stress test.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myocardial ischemia
Time Frame: 1-2 days per hospital SPECT protocol
|
The primary outcome is the presence of radionuclide evidence of focal myocardial ischemia evidenced on nuclear cardiac stress testing (SPECT results).
|
1-2 days per hospital SPECT protocol
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Salah Shafiq Al-Zaiti, PhD, University of Pittsburgh School of Nursing
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Respiratory Tract Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Respiration Disorders
- Pain
- Neurologic Manifestations
- Signs and Symptoms, Respiratory
- Coronary Disease
- Coronary Artery Disease
- Myocardial Ischemia
- Ischemia
- Chest Pain
- Angina Pectoris
- Dyspnea
Other Study ID Numbers
- PRO13070234
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chest Pain
-
Clinical Locomotion ScienceOdense University Hospital; University of Southern Denmark; The County of Funen... and other collaboratorsCompletedUndiagnosed Chest Pain | Musculoskeletal Chest Pain | Non-cardiac Chest PainDenmark
-
Academisch Medisch Centrum - Universiteit van Amsterdam...TerminatedFunctional Chest PainNetherlands
-
Queen's UniversityCompletedChest Pain Atypical SyndromeCanada
-
Ataturk UniversityCompletedPain, Acute | Pain, ChestTurkey
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Yichang Humanwell Pharmaceutical Co., Ltd., ChinaRecruiting
-
Fayoum University HospitalCompleted
-
University of Texas Southwestern Medical CenterCompletedAcute Chest PainUnited States
-
Massachusetts General HospitalBracco Diagnostics, IncCompletedChest Pain SyndromeUnited States
-
Universiti Sains MalaysiaCompletedNon Cardiac Chest PainMalaysia
-
Milton S. Hershey Medical CenterCompletedNoncardiac Chest Pain (NCCP)United States
Clinical Trials on 12-lead holter monitor application
-
Gillette Children's Specialty HealthcareTerminatedDravet Syndrome | Lennox-Gastaut SyndromeUnited States
-
RWTH Aachen UniversityCompletedEnd Stage Renal Disease | Diabetes Mellitus Type 2Germany
-
Leiden UniversityHerning Hospital; Medical Center Haaglanden; Groene Hart Ziekenhuis; Reinier de... and other collaboratorsTerminatedIschemic Stroke | Atrial Fibrillation | Transient Ischemic AttackNetherlands, Denmark
-
Murdoch Childrens Research InstituteCompleted
-
Dr Manvir Kaur HayerBritish Heart FoundationUnknownMyocardial Fibrosis | Chronic Kidney Diseases | Cardio-Renal Syndrome | Uraemic CardiomyopathyUnited Kingdom
-
Mayo ClinicAliveCorCompleted
-
Children's National Research InstituteEnrolling by invitationSyncope | Cardiac ArrhythmiaUnited States
-
University Hospital, BordeauxGrant Agreement ERC n°715093; University of Bordeaux - mission UB-C19CompletedCOVID-19 | Virus DiseaseFrance
-
University of UtahCompletedNeuro Developmental DelayUnited States
-
Boston Scientific CorporationNot yet recruitingOrthostatic Hypotension | Reflex SyncopeUnited States